Cipla Quality Chemical Industries Ltd (CQCIL)

Uganda
102.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    102.00 - 102.00

CQCIL Overview

Prev. Close
102
Day's Range
102 - 102
Revenue
238.52B
Open
102
52 wk Range
85 - 105
EPS
-6.35
Volume
0
Market Cap
372.49B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
0.99%
Shares Outstanding
3,651,909,200
Next Earnings Date
-
What is your sentiment on Cipla Quality Chemical Industries Ltd?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSell
Technical IndicatorsBuySell
SummaryNeutralSell

Cipla Quality Chemical Industries Ltd Company Profile

Cipla Quality Chemical Industries Ltd Company Profile

Employees
384
Market
Uganda

CIPLA Quality Chemical Industries Limited is a Uganda-based pharmaceutical manufacturing company. The Company's principal activity is manufacturing anti-retroviral drugs (ARVs) and Artemisinin-based Combination Therapies (ACTs) to combat human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and Malaria respectively. The Company also manufactures Hepatitis B medicines. The Company's products include anti-malarials, such as Lumartem; anti-retrovirals, such as Duovir-N, Duovir, Duomone, Efavir, Nevimune and Trioday, and Hepatitis B medicines, such as Texavir. Lumartem is a fixed dose ACT. Duovir-N is a fixed dose triple combination therapy used to treat HIV infection. Duomune is indicated in combination with at least one other antiretroviral medication for the treatment of HIV infection. Trioday is a triple fixed dose combination therapy used to treat HIV infection. Texavir is a montherapy of Tenofovir used to treat Hepatitis B.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.